This content is from: Premium
Hedge Funds Anticipate Another IPO
Biopharma companies are confident there is appetite for their shares.
Another hedge-fund-sponsored biopharmaceutical company has set its terms for going public.Oric Pharmaceuticals said it plans to offer 6.3 million shares at between $14 and $16 per share. Earlier in the week it had filed plans to offer 5 million shares in the same price range.Oric is the third biopharma company
To continue reading, subscribe now to Premium Journalism. Already a subscriber? Login.